The Electoral Commission has awarded a major $15.5 million advertising contract for next year’s general election to a ...

Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at AASLD's The Liver Meeting®, in ...

Microbix’s CEO & President, Cameron Groome, commented “Microbix regrets any impacts of international cybercrime and is continuing to improve its IT security at all levels. We appreciate the ...